Proteinuria in Pre and Post Transplant

Part of paid clinical trials in Miami, Florida.

Sponsor
University of Miami
Study ID
NCT01094327
Status
Recruiting
Apply to this trial

Conditions

  • Proteinuria

Eligibility Criteria

Sex
ALL
Age
N/A - 25 Years
Healthy Volunteers
Not accepted

Study Details

Patients with focal segmental glomerulosclerosis (FSGS) who progress rapidly to end stage renal disease (ESRD) are at highest risk for development of recurrence of proteinuria following kidney transplantation. This study will look at serum specimens pre and post transplant, as well as kidney transplant specimens pre and post reperfusion to identify where the defects has occured that results in recurrence of proteinuria in a given kidney transplant.

Key Dates

Start date
Feb 29, 2008
Status verified
Nov 2025
Primary completion
Nov 30, 2026
Completion
Nov 30, 2026

Study Design

Enrollment
100 participants (estimated)

Primary Outcome Measure

Explain mechanisms behind the development of proteinuria in patients immediately after receiving a kidney transplant [ Time Frame: through study completion, an average of 5 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Miami Miller School of Medicine Transplant ClinicMiamiFlorida33136
George Burke, M.D.
[email protected]
305-355-5111
George Burke, M.D. (PRINCIPAL_INVESTIGATOR)

Find similar trials in Miami, FL

By research site
University of Miami Miller School of Medicine Transplant Clinic· Miami, FL

Related Studies